X

Brian Robins

MNF shares hit new heights as investors have faith the telco will meet its profit target

The telco sector has been a graveyard for investors, but one player which is pushing into Asia has seen a…

How Opthea became a $1 billion stock in a month, and analysts reckon there’s still more to come

It’s not every day that a former doctoral student takes their thesis and turns it into a $1 billion venture,…

Here’s a microcap punting on bringing back Le Tan – and asset manager CVC wants in

Never heard of Heritage Brands? No reason why you should’ve, really, since it is a tiddler listed on what was…

This minnow saw off challenges from Japan and China to get a mine off the ground

With control of the one of the only large remaining laterite nickel deposits globally, Axiom Mining is the minnow that…

Insider buying could be a signal to cheer at troubled Smiles Inclusive

“Roll ups” - where lawyers, accountants or vets buy up rivals to boost economies of scale - have a mixed…

SomnoMed boss apologises for upsetting dentists, shares surge

The apology was heartfelt, but now the focus at medical devices outfit SomnoMed is on how it plans to reclaim…

What’s next for data encryptor Senetas as it waits for distributor buy-out

"Build the best widget and buyers will beat a path to your door" is the dream of many entrepreneurs. But…

What’s next for high-tech removalist Updater as positive cashflow beckons

Riding the wave of a dotcom hopeful as it breaks into earnings can be highly profitable as Xero investors have…

How tiddler telco United Networks is slowly righting the ship

It’s the tiddler telco with blue chip backers that raised $7.5 million when it went public a couple of years…

How the political storm over energy is impacting ASX renewable stocks

Global warming may have put renewables front of mind for those concerned about our energy future -- but for sharemarket…

A year after cold shower Acrux rebuild gets underway with first generic drug

It's coming up to a year since the cold shower that shook up drug maker Acrux, forcing it to launch a…

Why one of the market’s savviest investors put his money in a rival’s fund

Cheap money has led to surging market valuations over the past few years, with so-called "value" investors left behind if…

A dive into the US mortgage market could be a Credible move for this ASX fintech

Its latest earnings may have fallen short, but student loan comparison site Credible Labs still has fans as it pushes…

How should investors value disruptors like Micro-X, Reva, Visioneering and PainChek?

Its shares are trading at 36c, but if you listen to X-ray innovator Micro-X, it reckons a valuation of closer…

US roadblocks hurt Aussie green whistle maker Medical Developments

The Penthrox green whistle is an Aussie marvel of pain relief that has been available in this country for the…

Gold may be sinking but explorers like Alkane are ready to go shopping

It’s been a dog of a market for investors in small gold stocks, with a lacklustre gold price crushing valuations…

Baldness-fighter Cellmid launches hair-raising bid to raise $12m

A boost in Cellmid shares -- after US department stores Neiman Marcus and Bloomingdales stocked its hair products -- has…